Endoplasmic Reticulum-Mitochondria Calcium Communication and the Regulation of Mitochondrial Metabolism in Cancer: A Novel Potential Target

Cancer is characterized by an uncontrolled cell proliferation rate even under low nutrient availability, which is sustained by a metabolic reprograming now recognized as a hallmark of cancer. Warburg was the first to establish the relationship between cancer and mitochondria; however, he interpreted...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 7; p. 199
Main Authors Bustos, Galdo, Cruz, Pablo, Lovy, Alenka, Cárdenas, César
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 08.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer is characterized by an uncontrolled cell proliferation rate even under low nutrient availability, which is sustained by a metabolic reprograming now recognized as a hallmark of cancer. Warburg was the first to establish the relationship between cancer and mitochondria; however, he interpreted enhanced aerobic glycolysis as mitochondrial dysfunction. Today it is accepted that many cancer cell types need fully functional mitochondria to maintain their homeostasis. Calcium (Ca )-a key regulator of several cellular processes-has proven to be essential for mitochondrial metabolism. Inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca transfer from the endoplasmic reticulum to the mitochondria through the mitochondrial calcium uniporter (MCU) proves to be essential for the maintenance of mitochondrial function and cellular energy balance. Both IP3R and MCU are overexpressed in several cancer cell types, and the inhibition of the Ca communication between these two organelles causes proliferation arrest, migration decrease, and cell death through mechanisms that are not fully understood. In this review, we summarize and analyze the current findings in this area, emphasizing the critical role of Ca and mitochondrial metabolism in cancer and its potential as a novel therapeutic target.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Jan B. Parys, KU Leuven, Belgium
These authors have contributed equally to this work.
Specialty section: This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Reviewed by: Ildikò Szabò, University of Padua, Italy; Wolfgang F. Graier, Medical University of Graz, Austria
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2017.00199